HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Catherine M Kotz Selected Research
Catherine M Kotz Research Topics
Disease
19
Obesity
01/2023 - 12/2002
11
Body Weight (Weight, Body)
01/2022 - 07/2002
5
Weight Gain
01/2022 - 03/2008
4
Parkinson Disease (Parkinson's Disease)
01/2021 - 06/2005
3
Inflammation (Inflammations)
01/2021 - 10/2015
3
Cognitive Dysfunction
10/2019 - 10/2014
3
Hyperphagia (Overeating)
01/2016 - 04/2003
2
Sleep Wake Disorders
01/2022 - 03/2015
2
Gliosis
01/2021 - 01/2019
2
Narcolepsy
01/2021 - 03/2015
2
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 05/2010
1
Muscle Hypertonia
01/2023
1
Weight Loss (Weight Reduction)
01/2022
1
COVID-19
10/2021
1
Cataplexy
01/2021
1
Multiple Sclerosis
06/2020
1
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2020
1
Sleep Initiation and Maintenance Disorders (Insomnia)
03/2015
1
Neurodegenerative Diseases (Neurodegenerative Disease)
03/2015
1
Insulin Resistance
01/2013
1
Hypoglycemia (Reactive Hypoglycemia)
01/2013
1
Feeding and Eating Disorders (Eating Disorder)
05/2011
1
Tobacco Use Disorder (Nicotine Dependence)
04/2010
1
Starvation
07/2005
1
Anorexia
08/2002
Drug/Important Bio-Agent (IBA)
25
Orexins
IBA
01/2023 - 08/2002
7
Brain-Derived Neurotrophic Factor (BDNF)
IBA
10/2014 - 09/2007
5
Neuropeptides
IBA
03/2014 - 02/2006
4
Messenger RNA (mRNA)
IBA
12/2013 - 07/2005
3
Orexin Receptors
IBA
03/2015 - 10/2012
2
Neurotransmitter Agents (Neurotransmitter)
IBA
12/2017 - 01/2012
2
Peptides (Polypeptides)
IBA
02/2013 - 12/2002
2
Insulin (Novolin)
FDA Link
01/2013 - 05/2010
1
Endocrine Disruptors
IBA
01/2023
1
nornicotine
IBA
01/2022
1
anatabine
IBA
01/2022
1
Nicotine
FDA Link
01/2022
1
Anabasine
IBA
01/2022
1
Alkaloids
IBA
01/2022
1
Serotonin Receptors
IBA
01/2022
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2022
1
Vaccines
IBA
10/2021
1
COVID-19 Vaccines
IBA
10/2021
1
Topiramate (Topamax)
FDA Link
Generic
03/2021
1
alpha-Synuclein
IBA
01/2021
1
Fatty Acids (Saturated Fatty Acids)
IBA
10/2015
1
Palmitic Acid (Hexadecanoic Acid)
IBA
10/2015
1
Hypoxia-Inducible Factor 1
IBA
12/2013
1
Mitochondrial Uncoupling Proteins
IBA
01/2013
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2013
1
Fats
IBA
08/2012
1
Leptin
IBA
05/2010
1
Triglycerides (Triacylglycerol)
IBA
05/2010
1
Glucose (Dextrose)
FDA Link
Generic
05/2010
1
Neuropeptide Y
IBA
09/2007
1
trkB Receptor
IBA
09/2007
1
Sugars
IBA
10/2003
1
Sucrose (Saccharose)
IBA
10/2003
1
Uncoupling Protein 3
IBA
10/2003
1
Ghrelin
IBA
04/2003
1
Naltrexone (ReVia)
FDA Link
Generic
07/2002
Therapy/Procedure
4
Therapeutics
12/2013 - 05/2011
1
Drug Therapy (Chemotherapy)
01/2022
1
Injections
01/2022
1
Deep Brain Stimulation
06/2005